Search results

Evidence-based recommendations on volanesorsen (Waylivra) for treating familial chylomicronaemia syndrome in adults

Type

Highly specialised technologies guidance

Published

21 October 2020

Evidence-based recommendations on galcanezumab (Emgality) for preventing migraine in adults

Type

Technology appraisal guidance

Published

18 November 2020

Evidence-based recommendations on darolutamide (Nubeqa) for treating hormone-relapsed prostate cancer in adults at high risk of developing metastatic disease

Type

Technology appraisal guidance

Published

25 November 2020

Evidence-based recommendations on pembrolizumab (Keytruda) for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC) in a

Type

Technology appraisal guidance

Published

25 November 2020

NICE is unable to make a recommendation on durvalumab (Imfinzi) in combination for untreated extensive-stage small-cell lung cancer in adults because AstraZenec

Type

Technology appraisal guidance

Published

25 November 2020

Evidence-based recommendations on venetoclax (Venclyxto) with obinutuzumab for untreated chronic lymphocytic leukaemia in adults

Type

Technology appraisal guidance

Published

09 December 2020

Evidence-based recommendations on liraglutide (Saxenda) for managing overweight and obesity alongside a reduced-calorie diet and increased physical activity in

Type

Technology appraisal guidance

Published

09 December 2020

Evidence-based recommendations on upadacitinib (Rinvoq) for severe active rheumatoid arthritis in adults

Type

Technology appraisal guidance

Published

09 December 2020

Evidence-based recommendations on atezolizumab (Tecentriq) with bevacizumab (Avastin) for treating advanced or unresectable hepatocellular carcinoma in adults

Type

Technology appraisal guidance

Published

16 December 2020

Evidence-based recommendations on caplacizumab (Cablivi) with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic

Type

Technology appraisal guidance

Published

16 December 2020

Evidence-based recommendations on using coronary artery stents in adults

Type

Technology appraisal guidance

Last updated

18 November 2020

Evidence-based recommendations on naldemedine (Rizmoic) for treating opioid-induced constipation in adults who have had laxative treatment

Type

Technology appraisal guidance

Published

30 September 2020

NICE is unable to make a recommendation on alpelisib (Piqray) with fulvestrant for treating hormone-receptor positive, HER2-negative, PIK3CA-positive advanced

Type

Technology appraisal guidance

Published

07 October 2020

Evidence-based recommendations on osimertinib (Tagrisso) for treating epidermal growth factor receptor (EGFR) T790M mutation-positive locally advanced or

Type

Technology appraisal guidance

Published

14 October 2020

Evidence-based recommendations on osimertinib (Tagrisso) for untreated locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive

Type

Technology appraisal guidance

Published

14 October 2020

Evidence-based recommendations on nivolumab (Opdivo) for advanced squamous non-small-cell lung cancer in adults after chemotherapy

Type

Technology appraisal guidance

Published

21 October 2020

Evidence-based recommendations on siponimod (Mayzent) for treating secondary progressive multiple sclerosis in adults

Type

Technology appraisal guidance

Published

18 November 2020

Evidence-based recommendations on carfilzomib (Kyprolis) for previously treated multiple myeloma in adults

Type

Technology appraisal guidance

Published

18 November 2020

Evidence-based recommendations on isatuximab (Sarclisa) with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma in adults

Type

Technology appraisal guidance

Published

18 November 2020

Evidence-based recommendations on treosulfan (Trecondi) with fludarabine for conditioning treatment before allogeneic haematopoietic stem cell transplant for

Type

Technology appraisal guidance

Published

05 August 2020

Evidence-based recommendations on brentuximab vedotin (Adcetris) with cyclophosphamide, doxorubicin and prednisone for untreated systemic anaplastic large cell

Type

Technology appraisal guidance

Published

12 August 2020

Evidence-based recommendations on gilteritinib (Xospata) for relapsed or refractory FLT3-mutation-positive acute myeloid leukaemia in adults

Type

Technology appraisal guidance

Published

12 August 2020

Evidence-based recommendations on entrectinib (Rozlytrek) for ROS1-positive advanced non-small-cell lung cancer (NSCLC) in adults who have not had ROS1

Type

Technology appraisal guidance

Published

12 August 2020

Evidence-based recommendations on entrectinib (Rozlytrek) for treating neurotrophic tyrosine receptor kinase (NTRK) fusion-positive solid tumours in adults and

Type

Technology appraisal guidance

Published

12 August 2020

Evidence-based recommendations on avelumab (Bavencio) with axitinib (Inlyta) for untreated advanced renal cell carcinoma in adults

Type

Technology appraisal guidance

Published

02 September 2020

NICE is unable to make a recommendation on glasdegib with chemotherapy for untreated acute myeloid leukaemia because Pfizer did not provide an evidence

Type

Technology appraisal guidance

Published

02 September 2020

NICE is unable to make a recommendation about the use in the NHS of eculizumab (Soliris) for treating relapsing neuromyelitis optica because Alexion Pharma UK

Type

Technology appraisal guidance

Published

02 September 2020

NICE is unable to make a recommendation on dupilumab (Dupixent) for treating chronic rhinosinusitis with nasal polyps because Sanofi did not provide an evidence

Type

Technology appraisal guidance

Published

09 September 2020

Evidence-based recommendations on polatuzumab vedotin (Polivy) with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphoma

Type

Technology appraisal guidance

Published

23 September 2020

Evidence-based recommendations on pembrolizumab (Keytruda) with axitinib (Inlyta) for untreated advanced renal cell carcinoma in adults

Type

Technology appraisal guidance

Published

30 September 2020

Evidence-based recommendations on using drug-eluting stents in adults

Type

Technology appraisal guidance

Last updated

18 November 2020

Evidence-based recommendations on encorafenib (Braftovi) plus cetuximab (Erbitux) for treating BRAF V600E mutation-positive metastatic colorectal cancer in

Type

Technology appraisal guidance

Published

06 January 2021

Evidence-based recommendations on trifluridine–tipiracil (Lonsurf) for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma in adult

Type

Technology appraisal guidance

Published

27 January 2021

Evidence-based recommendations on brigatinib (Alunbrig) for anaplastic lymphoma kinase (ALK)-positive advanced non-small-cell lung cancer that has not been

Type

Technology appraisal guidance

Published

27 January 2021

Evidence-based recommendations on transcranial magnetic stimulation for auditory hallucinations. This involves stimulating the brain with pulses of

Type

Interventional procedures guidance

Published

23 September 2020

Evidence-based recommendations on deep brain stimulation for refractory epilepsy in adults. This involves implanting an electrical stimulator in the brain

Type

Interventional procedures guidance

Published

12 August 2020

Evidence-based recommendations on vagus nerve stimulation for treatment-resistant depression in adults. This involves implanting an electrical stimulator under

Type

Interventional procedures guidance

Published

12 August 2020

Evidence-based recommendations on transcranial magnetic stimulation for obsessive-compulsive disorder in adults. This involves pulsing electromagnetic energy

Type

Interventional procedures guidance

Published

05 August 2020

Evidence-based recommendations on electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney

Type

Interventional procedures guidance

Published

05 August 2020

Evidence-based recommendations on swallowable gastric balloon capsules for weight loss in adults. This involves swallowing a capsule containing a balloon that

Type

Interventional procedures guidance

Published

18 November 2020

Evidence-based recommendations on pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis in adults. This involves spraying the inside of

Type

Interventional procedures guidance

Published

28 October 2020

Evidence-based recommendations on balloon cryoablation for Barrett’s oesophagus. This involves using a balloon filled with cold gas to destroy abnormal cells

Type

Interventional procedures guidance

Published

28 October 2020

Evidence-based recommendations on balloon cryoablation for squamous dysplasia of the oesophagus. This involves using a balloon filled with cold gas to destroy

Type

Interventional procedures guidance

Published

28 October 2020

Evidence-based recommendations on self-expanding implant insertion into the intersphincteric space for faecal incontinence. This involves inserting implants

Type

Interventional procedures guidance

Published

27 January 2021

Evidence-based recommendations on minimally invasive radical hysterectomy for early stage cervical cancer. This involves removing the uterus, cervix, upper

Type

Interventional procedures guidance

Published

27 January 2021